Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity
Year: 2004
Type: article
Source: Clinical Cancer Research
Institutions: University of Pennsylvania, Biogen (United States)
Language: English
Topic: TGF-β signaling in diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: U.S. Public Health Service
Award: G1970312965
OpenAlex ID: W2023961961
